Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6782)
All Articles published online
|
Publishing Process of This Article
|
Mar 15, 2020 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ricci V, Granetto C, Falletta A, Paccagnella M, Abbona A, Fea E, Fabozzi T, Lo Nigro C, Merlano MC. Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib. World J Gastrointest Oncol 2020; 12(3): 301-310 [PMID: 32206180 DOI: 10.4251/wjgo.v12.i3.301] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i3/301.htm |
| Number | Citing Articles |
| 1 |
Marco Carlo Merlano, Matteo Paccagnella, Nerina Denaro, Andrea Abbona, Danilo Galizia, Dario Sangiolo, Loretta Gammaitoni, Erika Fiorino, Silvia Minei, Paolo Bossi, Lisa Licitra, Ornella Garrone. Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment. Cancers 2023; 15(21): 5257 doi: 10.3390/cancers15215257
|
| 2 |
Xiaoshuang Li, Yanmin Wu, Tian Tian. TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development. International Journal of Molecular Sciences 2022; 23(22): 14436 doi: 10.3390/ijms232214436
|
| 3 |
Andrea Abbona, Vincenzo Ricci, Matteo Paccagnella, Cristina Granetto, Fiorella Ruatta, Carolina Cauchi, Danilo Galizia, Michele Ghidini, Nerina Denaro, Marco Carlo Merlano, Ornella Garrone. Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib. Vaccines 2023; 11(2): 335 doi: 10.3390/vaccines11020335
|
| 4 |
Valentina De Nunzio, Rossella Donghia, Pasqua L. Pesole, Sergio Coletta, Nicola Calò, Maria Notarnicola. Serum Cytokine and miRNA Levels Are Differently Expressed in Right- and Left-Sided Colon Cancer. Journal of Clinical Medicine 2023; 12(18): 5986 doi: 10.3390/jcm12185986
|
| 5 |
Sylvia Grünewald, Maria Stecklum, Manuel Rizzo, Jonathan Rathjens, Lukas Fiebig, Dieter Zopf. Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice. European Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01099-2
|
| 6 |
Simona De Summa, Katia Danza, Brunella Pilato, Giuseppina Matera, Rossella Fasano, Angela Calabrese, Rosanna Lacalamita, Nicola Silvestris, Stefania Tommasi, Antonella Argentiero, Oronzo Brunetti. A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report. Medicina 2021; 57(11): 1241 doi: 10.3390/medicina57111241
|